New salmeterol/fluticasone MDI extends choice in asthma prescribing

Aloflute (salmeterol/fluticasone) metered dose inhaler is licensed for the treatment of asthma where use of a combination product is appropriate.

To continue reading you need to be a registered user or subscriber

Existing users login here

Need help? Email us

Not registered? Sign up now for FREE access to:

  • GP online

Registered GPs also have FREE access to:

  • intelog online
  • intelog print*

Want access to intelog and not a GP?

*Fully qualified GPs based in NHS practices only. All other GPs can access intelog in print by subscription